Unbiased Analysis of Today's Healthcare Issues

Archive for the 'Current Events' Category

Are you going to be working on Labor Day?

According to an article in the American Psychological Association webpage, the answer is likely ‘yes’. Originally intended as a day for relaxation and celebration of the American worker, Labor Day today is very different from the first Labor Day in 1882. Back then, a largely industrial and agricultural workforce could disconnect from work on Labor Day […]

Read the rest of this entry »

DA Henderson, RIP

The man, Donal Ainslie (DA) Anderson, whole help eliminate smallpox died on August 19.  The Economist has an obituary to the man. This crowd of helpers, which delighted him, meant that no Nobel prize could be given for wiping out smallpox. If it had been, he might have shared it with William Foege, who first devised […]

Read the rest of this entry »

The End of the Obamacare Exchanges

Princeton economist Uwe Reinhardt things so.  In an interview with Vox he states: The natural business model of a private commercial insurer is to price on health status and have the flexibility to raise prices year after year. What we’ve tried to do, instead, is do community rating [where insurers can’t price on how sick […]

Read the rest of this entry »

Thursday Links

Part D drug spending grows 17%. Should alcoholics get liver transplants? Why isn’t personalized medicine here yet? Is the public option doomed? Whose lives should be saved?

Read the rest of this entry »

Weekend Links

Biosimilars: A guide. Is it time to end of the donut hole? The five biggest questions in (macro)economics. FDA and poop regulation. Value framework conference. NHS cancer patients missing out innovative drugs.

Read the rest of this entry »

VBID comes to Medicare Advantage

CMS announced last week that they are extending their value-based insurance design (VBID) program to more states and more patients.  I describe VBID and the proposed changes below. What is VBID? Value-Based Insurance Design (VBID) generally refers to health insurers’ efforts to structure enrollee cost sharing and other health plan design elements to encourage enrollees […]

Read the rest of this entry »

Friday Links

Google partners with GSK to form biotech firm. You are 6x more likely to be killed by the police in the US than in Canada. ICER myths? One area without racial disparities? 2 million Medicare beneficiaries are homebound.  How will they get the medical care they need?

Read the rest of this entry »

Clinton vs. Trump: A Healthcare Comparison

AJMC has a nice article summarizing some of the key differences between the two presidential candidates.  I paraphrase the article below. The future of the Affordable Care Act (ACA). Clinton wants to keep or even expand the ACA and wants to cap out-of-pocket drug costs.  Clinton has even called for a public option. On the […]

Read the rest of this entry »

Impact of Brexit on Pharma

There is a lot of talk that Brexit will be a disaster.  While I believe that much of this disaster talk is overblown, there are clear business implications.  Pharmafile provides an example of how Brexit would affect a small pharmaceutical company conducting clinical trials in the UK. In the latter case, UK-based pharmaceutical companies with no other […]

Read the rest of this entry »

Friday Links

Progress in the fight against pancreatic cancer? Pouring billions down the drain? Does calorie labeling work? When life gives you MACRA. A one size fits all formulary policy?

Read the rest of this entry »